ADVERTISEMENT

Joel M. Gelfand, MD, MSCE

Cover Story

Cardiovascular Risk and Psoriasis

10/20/2023

Joel M. Gelfand, MD, MSCE

Heart disease is the #1 killer in the United States. By screening our patients with psoriasis who are predisposed to heart disease for cardiovascular risk factors, we can help them live longer, healthier lives.

Heart disease is the #1 killer in the United States. By screening our patients with psoriasis who are predisposed to heart disease for cardiovascular risk factors, we can help them live longer, healthier lives.

Heart disease is the #1 killer...

10/20/2023

The Dermatologist

Current Considerations in the Treatment of Psoriasis With Phototherapy

Partner Approved

Current Considerations in the Treatment of Psoriasis With Phototherapy

08/13/2020

Joel M. Gelfand, MD, MSCE

Phototherapy continues to be a mainstay of psoriasis treatment. Dr Gelfand highlights recommendations for phototherapy administration and patient discussions during the COVID-19 pandemic.

Phototherapy continues to be a mainstay of psoriasis treatment. Dr Gelfand highlights recommendations for phototherapy administration and patient discussions during the COVID-19 pandemic.

Phototherapy continues to be a...

08/13/2020

The Dermatologist

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Advertisement

Advertisement

Advertisement

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

DCLF

March 17 ⁠–⁠ March 19

See Full Calendar

Advertisement

Advertisement